Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9.

An orphan nuclear receptor, Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1), is essential for the development and function of steroidogenic tissues. To examine the transcriptional regulation of Ad4BP/SF-1, two-hybrid screening was performed, and the sumoylation [conjugation of a small ubiqutin-like modifier (SUMO-1)] components Ubc9, protein inhibitor of activated STAT 1 (PIAS1), and protein inhibitor of activated STAT 3 (PIAS3) were isolated. Cultured cell and in vitro studies revealed that Ad4BP/SF-1 is sumoylated at K119 and K194. Because K194 lies within the synergy control (SC) motif defined to repress synergistic transcription from promoters containing multiple binding sites, correlation between the functions of the SC motif and sumoylation was investigated. The K194R mutant of Ad4BP/SF-1, which cannot be sumoylated, showed enhanced synergistic transcription from a promoter containing multiple Ad4/SF-1 sites, suggesting that sumoylation is necessary for repression of transcriptional synergy through the SC motif. It has been established that the Müllerian inhibiting substance gene is transcribed predominantly under the control of Ad4BP/SF-1 and, moreover, its transcription is regulated synergistically with Sox9, Gata4, and Wt1. Interestingly, it was found that all of these factors are sumoylated, and these sumoylation sites occur within SC motifs. Based on the observation that SC motif mutants of Ad4BP/SF-1 and Sox9 resulted in the enhancement of their synergistic transcription, it was concluded that the SC motif regulates synergistic transcription even between distinct types of transcription factors. Considering that both mutants cannot be sumoylated, it is likely that sumoylation is implicated in this regulation. Because it was revealed with an in vitro sumoylated Ad4BP/SF-1 that DNA binding activity and interaction with Sox9 were unaffected, sumoylation may regulate transcription through affecting selective and cooperative interaction among factors constituting transcriptional complexes.

[1]  F. Huang,et al.  SUMO Modification of Repression Domains Modulates Function of Nuclear Receptor 5A1 (Steroidogenic Factor-1)* , 2004, Journal of Biological Chemistry.

[2]  A. Sharrocks,et al.  SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.

[3]  J. Iñiguez-Lluhí,et al.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Anwar Hossain,et al.  Role of Wilms Tumor 1 (WT1) in the Transcriptional Regulation of the Mullerian-Inhibiting Substance Promoter1 , 2003, Biology of reproduction.

[5]  C. Kedinger,et al.  The ‘PINIT’ motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L , 2003, FEBS letters.

[6]  G. Mellgren,et al.  Cloning and characterization of a novel zinc finger protein that modulates the transcriptional activity of nuclear receptors. , 2003, Molecular endocrinology.

[7]  A. Dejean,et al.  Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.

[8]  Fang Liu,et al.  Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Andrew D Sharrocks,et al.  Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity. , 2003, Molecular cell.

[10]  F. Melchior,et al.  Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. , 2003, Molecular cell.

[11]  N. Perkins,et al.  P300 transcriptional repression is mediated by SUMO modification. , 2003, Molecular cell.

[12]  G. Gill,et al.  Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. , 2003, Current opinion in genetics & development.

[13]  A. Swain,et al.  Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad. , 2003, Molecular endocrinology.

[14]  M. Waterman,et al.  cAMP-dependent Protein Kinase Enhances CYP17 Transcription via MKP-1 Activation in H295R Human Adrenocortical Cells* , 2003, The Journal of Biological Chemistry.

[15]  J. Iñiguez-Lluhí,et al.  A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3* , 2003, The Journal of Biological Chemistry.

[16]  向井 徳男.  Sexually dimorphic expression of Dax-1 in the adrenal cortex , 2003 .

[17]  D. Hum,et al.  The Transcriptional Regulating Protein of 132 kDa (TReP-132) Enhances P450scc Gene Transcription through Interaction with Steroidogenic Factor-1 in Human Adrenal Cells* , 2002, The Journal of Biological Chemistry.

[18]  R. Fletterick,et al.  Phosphorylation and Intramolecular Stabilization of the Ligand Binding Domain in the Nuclear Receptor Steroidogenic Factor 1 , 2002, Molecular and Cellular Biology.

[19]  L. Zon,et al.  SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. , 2002, Molecular cell.

[20]  F. Ruddle,et al.  Physical and functional interactions of histone deacetylase 3 with TFII-I family proteins and PIASxβ , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Boris Pfander,et al.  RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO , 2002, Nature.

[22]  M. Kusaka,et al.  Sexually dimorphic expression of Dax‐1 in the adrenal cortex , 2002, Genes to cells : devoted to molecular & cellular mechanisms.

[23]  G. Mellgren,et al.  The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. , 2002, Molecular endocrinology.

[24]  J. Markus,et al.  Covalent Attachment of the SUMO-1 Protein to the Negative Regulatory Domain of the c-Myb Transcription Factor Modifies Its Stability and Transactivation Capacity* , 2002, The Journal of Biological Chemistry.

[25]  S. Müller,et al.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Courey,et al.  Conjugation of Smt3 to Dorsal May Potentiate the Drosophila Immune Response , 2002, Molecular and Cellular Biology.

[27]  L. Bruhn,et al.  PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. , 2001, Genes & development.

[28]  J. Lund,et al.  Acetylation of Steroidogenic Factor 1 Protein Regulates Its Transcriptional Activity and Recruits the Coactivator GCN5* , 2001, The Journal of Biological Chemistry.

[29]  J. Jorgensen,et al.  AR suppresses transcription of the LHbeta subunit by interacting with steroidogenic factor-1. , 2001, Molecular endocrinology.

[30]  Y. Sadovsky,et al.  The DEAD box protein DP103 is a regulator of steroidogenic factor-1. , 2001, Molecular endocrinology.

[31]  J. Iñiguez-Lluhí,et al.  A Common Motif within the Negative Regulatory Regions of Multiple Factors Inhibits Their Transcriptional Synergy , 2000, Molecular and Cellular Biology.

[32]  F. Melchior,et al.  SUMO--nonclassical ubiquitin. , 2000, Annual review of cell and developmental biology.

[33]  M. Shirakawa,et al.  The Role of Human MBF1 as a Transcriptional Coactivator* , 1999, The Journal of Biological Chemistry.

[34]  B. Chung,et al.  Function of steroidogenic factor 1 domains in nuclear localization, transactivation, and interaction with transcription factor TFIIB and c-Jun. , 1999, Molecular endocrinology.

[35]  J. Tremblay,et al.  Transcription factor GATA-4 enhances Müllerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1. , 1999, Molecular endocrinology.

[36]  J. Drouin,et al.  Ptx1 regulates SF‐1 activity by an interaction that mimics the role of the ligand‐binding domain , 1999, The EMBO journal.

[37]  Y. Sadovsky,et al.  Activation of luteinizing hormone beta gene by gonadotropin-releasing hormone requires the synergy of early growth response-1 and steroidogenic factor-1. , 1999, The Journal of biological chemistry.

[38]  G. Hammer,et al.  Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. , 1999, Molecular cell.

[39]  H. Sasano,et al.  Structural and functional abnormalities in the spleen of an mFtz-F1 gene-disrupted mouse. , 1999, Blood.

[40]  K. Yamamoto,et al.  Glucocorticoid Receptor Transcriptional Activity Determined by Spacing of Receptor and Nonreceptor DNA Sites* , 1998, The Journal of Biological Chemistry.

[41]  Gerd Scherer,et al.  Direct Interaction of SRY-Related Protein SOX9 and Steroidogenic Factor 1 Regulates Transcription of the Human Anti-Müllerian Hormone Gene , 1998, Molecular and Cellular Biology.

[42]  R. Hay,et al.  SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. , 1998, Molecular cell.

[43]  J. Jameson,et al.  Steroidogenic Factor-1 and Early Growth Response Protein 1 Act through Two Composite DNA Binding Sites to Regulate Luteinizing Hormone β-Subunit Gene Expression* , 1998, The Journal of Biological Chemistry.

[44]  J. Milbrandt,et al.  Nuclear Receptor DAX-1 Recruits Nuclear Receptor Corepressor N-CoR to Steroidogenic Factor 1 , 1998, Molecular and Cellular Biology.

[45]  G. Hammer,et al.  Wilms' Tumor 1 and Dax-1 Modulate the Orphan Nuclear Receptor SF-1 in Sex-Specific Gene Expression , 1998, Cell.

[46]  D. Monté,et al.  Regulation of the Human P450scc Gene by Steroidogenic Factor 1 Is Mediated by CBP/p300* , 1998, The Journal of Biological Chemistry.

[47]  M. Ito,et al.  Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. , 1998, Molecular endocrinology.

[48]  Y. Sadovsky,et al.  The activation function-2 hexamer of steroidogenic factor-1 is required, but not sufficient for potentiation by SRC-1. , 1997, Molecular endocrinology.

[49]  M. Ito,et al.  DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita , 1997, Molecular and cellular biology.

[50]  J. Milbrandt,et al.  Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Nagano,et al.  Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz‐F1 disrupted mice , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[52]  K. Parker,et al.  A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation , 1994, Cell.

[53]  M. Waterman,et al.  Activation of CYP11A and CYP11B gene promoters by the steroidogenic cell-specific transcription factor, Ad4BP. , 1993, Molecular endocrinology.

[54]  S. Honda,et al.  Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. , 1993, The Journal of biological chemistry.

[55]  H. Ueda,et al.  A novel DNA-binding motif abuts the zinc finger domain of insect nuclear hormone receptor FTZ-F1 and mouse embryonal long terminal repeat-binding protein. , 1992, Molecular and cellular biology.

[56]  H. Handa,et al.  A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450s. , 1992, The Journal of biological chemistry.

[57]  K. Parker,et al.  Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. , 1992, Molecular endocrinology.

[58]  D. Housman,et al.  Alternative splicing and genomic structure of the Wilms tumor gene WT1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[59]  K. Umesono,et al.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.